Extended Release Drug Market, Global Outlook and Forecast 2022-2028

March 2022 | 68 pages | ID: E5EA53525149EN
Market Monitor Global

Abstracts

Drug delivery systems are engineered technologies for controlled release of drugs or to the targeted delivery of drugs. Drug delivery system is a kind of formulation that enables the administration of therapeutic agents in the body and improves its safety and efficacy by controlling the time, rate and place of drug release in the body. Most of the conventional oral products of drugs are formulated to release the active ingredient as soon as it is administered. Now the pattern has been changed to modified release dosage forms to achieve better therapeutic target. Extended release drugs is a type of dosage forms which allows a two-fold reduction in frequency of dosage administered in the body.

This report contains market size and forecasts of Extended Release Drug in Global, including the following market information:

Global Extended Release Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Extended Release Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Sustained Release Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Extended Release Drug include Pfizer, Mallinckrodt, Teva, Johnson & Johnson, Endo Pharmaceuticals, Purdue Pharma, Mylan, Hisamitsu Pharmaceutical and Sun Pharmaceutical Industries. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Extended Release Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Extended Release Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Extended Release Drug Market Segment Percentages, by Type, 2021 (%)

• Sustained Release Drug
• Controlled Release Drug

Global Extended Release Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Extended Release Drug Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Global Extended Release Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Extended Release Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Extended Release Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Extended Release Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Mallinckrodt
• Teva
• Johnson & Johnson
• Endo Pharmaceuticals
• Purdue Pharma
• Mylan
• Hisamitsu Pharmaceutical
• Sun Pharmaceutical Industries

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Extended Release Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Extended Release Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL EXTENDED RELEASE DRUG OVERALL MARKET SIZE

2.1 Global Extended Release Drug Market Size: 2021 VS 2028
2.2 Global Extended Release Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Extended Release Drug Players in Global Market
3.2 Top Global Extended Release Drug Companies Ranked by Revenue
3.3 Global Extended Release Drug Revenue by Companies
3.4 Top 3 and Top 5 Extended Release Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Extended Release Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Extended Release Drug Players in Global Market
  3.6.1 List of Global Tier 1 Extended Release Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Extended Release Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Extended Release Drug Market Size Markets, 2021 & 2028
  4.1.2 Sustained Release Drug
  4.1.3 Controlled Release Drug
4.2 By Type - Global Extended Release Drug Revenue & Forecasts
  4.2.1 By Type - Global Extended Release Drug Revenue, 2017-2022
  4.2.2 By Type - Global Extended Release Drug Revenue, 2023-2028
  4.2.3 By Type - Global Extended Release Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Extended Release Drug Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacy
  5.1.3 Retail Pharmacy
  5.1.4 Online Pharmacy
5.2 By Application - Global Extended Release Drug Revenue & Forecasts
  5.2.1 By Application - Global Extended Release Drug Revenue, 2017-2022
  5.2.2 By Application - Global Extended Release Drug Revenue, 2023-2028
  5.2.3 By Application - Global Extended Release Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Extended Release Drug Market Size, 2021 & 2028
6.2 By Region - Global Extended Release Drug Revenue & Forecasts
  6.2.1 By Region - Global Extended Release Drug Revenue, 2017-2022
  6.2.2 By Region - Global Extended Release Drug Revenue, 2023-2028
  6.2.3 By Region - Global Extended Release Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Extended Release Drug Revenue, 2017-2028
  6.3.2 US Extended Release Drug Market Size, 2017-2028
  6.3.3 Canada Extended Release Drug Market Size, 2017-2028
  6.3.4 Mexico Extended Release Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Extended Release Drug Revenue, 2017-2028
  6.4.2 Germany Extended Release Drug Market Size, 2017-2028
  6.4.3 France Extended Release Drug Market Size, 2017-2028
  6.4.4 U.K. Extended Release Drug Market Size, 2017-2028
  6.4.5 Italy Extended Release Drug Market Size, 2017-2028
  6.4.6 Russia Extended Release Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Extended Release Drug Market Size, 2017-2028
  6.4.8 Benelux Extended Release Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Extended Release Drug Revenue, 2017-2028
  6.5.2 China Extended Release Drug Market Size, 2017-2028
  6.5.3 Japan Extended Release Drug Market Size, 2017-2028
  6.5.4 South Korea Extended Release Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Extended Release Drug Market Size, 2017-2028
  6.5.6 India Extended Release Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Extended Release Drug Revenue, 2017-2028
  6.6.2 Brazil Extended Release Drug Market Size, 2017-2028
  6.6.3 Argentina Extended Release Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Extended Release Drug Revenue, 2017-2028
  6.7.2 Turkey Extended Release Drug Market Size, 2017-2028
  6.7.3 Israel Extended Release Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Extended Release Drug Market Size, 2017-2028
  6.7.5 UAE Extended Release Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Extended Release Drug Major Product Offerings
  7.1.4 Pfizer Extended Release Drug Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Key News
7.2 Mallinckrodt
  7.2.1 Mallinckrodt Corporate Summary
  7.2.2 Mallinckrodt Business Overview
  7.2.3 Mallinckrodt Extended Release Drug Major Product Offerings
  7.2.4 Mallinckrodt Extended Release Drug Revenue in Global Market (2017-2022)
  7.2.5 Mallinckrodt Key News
7.3 Teva
  7.3.1 Teva Corporate Summary
  7.3.2 Teva Business Overview
  7.3.3 Teva Extended Release Drug Major Product Offerings
  7.3.4 Teva Extended Release Drug Revenue in Global Market (2017-2022)
  7.3.5 Teva Key News
7.4 Johnson & Johnson
  7.4.1 Johnson & Johnson Corporate Summary
  7.4.2 Johnson & Johnson Business Overview
  7.4.3 Johnson & Johnson Extended Release Drug Major Product Offerings
  7.4.4 Johnson & Johnson Extended Release Drug Revenue in Global Market (2017-2022)
  7.4.5 Johnson & Johnson Key News
7.5 Endo Pharmaceuticals
  7.5.1 Endo Pharmaceuticals Corporate Summary
  7.5.2 Endo Pharmaceuticals Business Overview
  7.5.3 Endo Pharmaceuticals Extended Release Drug Major Product Offerings
  7.5.4 Endo Pharmaceuticals Extended Release Drug Revenue in Global Market (2017-2022)
  7.5.5 Endo Pharmaceuticals Key News
7.6 Purdue Pharma
  7.6.1 Purdue Pharma Corporate Summary
  7.6.2 Purdue Pharma Business Overview
  7.6.3 Purdue Pharma Extended Release Drug Major Product Offerings
  7.6.4 Purdue Pharma Extended Release Drug Revenue in Global Market (2017-2022)
  7.6.5 Purdue Pharma Key News
7.7 Mylan
  7.7.1 Mylan Corporate Summary
  7.7.2 Mylan Business Overview
  7.7.3 Mylan Extended Release Drug Major Product Offerings
  7.7.4 Mylan Extended Release Drug Revenue in Global Market (2017-2022)
  7.7.5 Mylan Key News
7.8 Hisamitsu Pharmaceutical
  7.8.1 Hisamitsu Pharmaceutical Corporate Summary
  7.8.2 Hisamitsu Pharmaceutical Business Overview
  7.8.3 Hisamitsu Pharmaceutical Extended Release Drug Major Product Offerings
  7.8.4 Hisamitsu Pharmaceutical Extended Release Drug Revenue in Global Market (2017-2022)
  7.8.5 Hisamitsu Pharmaceutical Key News
7.9 Sun Pharmaceutical Industries
  7.9.1 Sun Pharmaceutical Industries Corporate Summary
  7.9.2 Sun Pharmaceutical Industries Business Overview
  7.9.3 Sun Pharmaceutical Industries Extended Release Drug Major Product Offerings
  7.9.4 Sun Pharmaceutical Industries Extended Release Drug Revenue in Global Market (2017-2022)
  7.9.5 Sun Pharmaceutical Industries Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Extended Release Drug Market Opportunities & Trends in Global Market
Table 2. Extended Release Drug Market Drivers in Global Market
Table 3. Extended Release Drug Market Restraints in Global Market
Table 4. Key Players of Extended Release Drug in Global Market
Table 5. Top Extended Release Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Extended Release Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Extended Release Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Extended Release Drug Product Type
Table 9. List of Global Tier 1 Extended Release Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Extended Release Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Extended Release Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Extended Release Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Extended Release Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Extended Release Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Extended Release Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Extended Release Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Extended Release Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Extended Release Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Extended Release Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Extended Release Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Extended Release Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Extended Release Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Extended Release Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Extended Release Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Extended Release Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Extended Release Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Extended Release Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Extended Release Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Extended Release Drug Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Extended Release Drug Product Offerings
Table 32. Pfizer Extended Release Drug Revenue (US$, Mn), (2017-2022)
Table 33. Mallinckrodt Corporate Summary
Table 34. Mallinckrodt Extended Release Drug Product Offerings
Table 35. Mallinckrodt Extended Release Drug Revenue (US$, Mn), (2017-2022)
Table 36. Teva Corporate Summary
Table 37. Teva Extended Release Drug Product Offerings
Table 38. Teva Extended Release Drug Revenue (US$, Mn), (2017-2022)
Table 39. Johnson & Johnson Corporate Summary
Table 40. Johnson & Johnson Extended Release Drug Product Offerings
Table 41. Johnson & Johnson Extended Release Drug Revenue (US$, Mn), (2017-2022)
Table 42. Endo Pharmaceuticals Corporate Summary
Table 43. Endo Pharmaceuticals Extended Release Drug Product Offerings
Table 44. Endo Pharmaceuticals Extended Release Drug Revenue (US$, Mn), (2017-2022)
Table 45. Purdue Pharma Corporate Summary
Table 46. Purdue Pharma Extended Release Drug Product Offerings
Table 47. Purdue Pharma Extended Release Drug Revenue (US$, Mn), (2017-2022)
Table 48. Mylan Corporate Summary
Table 49. Mylan Extended Release Drug Product Offerings
Table 50. Mylan Extended Release Drug Revenue (US$, Mn), (2017-2022)
Table 51. Hisamitsu Pharmaceutical Corporate Summary
Table 52. Hisamitsu Pharmaceutical Extended Release Drug Product Offerings
Table 53. Hisamitsu Pharmaceutical Extended Release Drug Revenue (US$, Mn), (2017-2022)
Table 54. Sun Pharmaceutical Industries Corporate Summary
Table 55. Sun Pharmaceutical Industries Extended Release Drug Product Offerings
Table 56. Sun Pharmaceutical Industries Extended Release Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Extended Release Drug Segment by Type in 2021
Figure 2. Extended Release Drug Segment by Application in 2021
Figure 3. Global Extended Release Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Extended Release Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Extended Release Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Extended Release Drug Revenue in 2021
Figure 8. By Type - Global Extended Release Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Extended Release Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Extended Release Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Extended Release Drug Revenue Market Share, 2017-2028
Figure 12. US Extended Release Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Extended Release Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Extended Release Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Extended Release Drug Revenue Market Share, 2017-2028
Figure 16. Germany Extended Release Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Extended Release Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Extended Release Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Extended Release Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Extended Release Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Extended Release Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Extended Release Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Extended Release Drug Revenue Market Share, 2017-2028
Figure 24. China Extended Release Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Extended Release Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Extended Release Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Extended Release Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Extended Release Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Extended Release Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Extended Release Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Extended Release Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Extended Release Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Extended Release Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Extended Release Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Extended Release Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Extended Release Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Extended Release Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Mallinckrodt Extended Release Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Teva Extended Release Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Johnson & Johnson Extended Release Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Endo Pharmaceuticals Extended Release Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Purdue Pharma Extended Release Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Mylan Extended Release Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Hisamitsu Pharmaceutical Extended Release Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Sun Pharmaceutical Industries Extended Release Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)